全文获取类型
收费全文 | 28341篇 |
免费 | 2178篇 |
国内免费 | 66篇 |
专业分类
耳鼻咽喉 | 233篇 |
儿科学 | 1027篇 |
妇产科学 | 865篇 |
基础医学 | 3510篇 |
口腔科学 | 430篇 |
临床医学 | 5148篇 |
内科学 | 4913篇 |
皮肤病学 | 387篇 |
神经病学 | 2667篇 |
特种医学 | 522篇 |
外科学 | 2274篇 |
综合类 | 388篇 |
一般理论 | 64篇 |
预防医学 | 3927篇 |
眼科学 | 343篇 |
药学 | 1604篇 |
中国医学 | 26篇 |
肿瘤学 | 2257篇 |
出版年
2023年 | 161篇 |
2022年 | 220篇 |
2021年 | 489篇 |
2020年 | 415篇 |
2019年 | 714篇 |
2018年 | 738篇 |
2017年 | 553篇 |
2016年 | 660篇 |
2015年 | 727篇 |
2014年 | 915篇 |
2013年 | 1448篇 |
2012年 | 1983篇 |
2011年 | 2005篇 |
2010年 | 1108篇 |
2009年 | 1007篇 |
2008年 | 1885篇 |
2007年 | 2020篇 |
2006年 | 2014篇 |
2005年 | 1911篇 |
2004年 | 1794篇 |
2003年 | 1725篇 |
2002年 | 1625篇 |
2001年 | 240篇 |
2000年 | 200篇 |
1999年 | 232篇 |
1998年 | 397篇 |
1997年 | 279篇 |
1996年 | 275篇 |
1995年 | 257篇 |
1994年 | 226篇 |
1993年 | 222篇 |
1992年 | 136篇 |
1991年 | 112篇 |
1990年 | 110篇 |
1989年 | 117篇 |
1988年 | 103篇 |
1987年 | 81篇 |
1986年 | 99篇 |
1985年 | 121篇 |
1984年 | 103篇 |
1983年 | 110篇 |
1982年 | 137篇 |
1981年 | 134篇 |
1980年 | 137篇 |
1979年 | 51篇 |
1978年 | 57篇 |
1977年 | 56篇 |
1976年 | 60篇 |
1975年 | 50篇 |
1974年 | 45篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
32.
Christina M Marra Clare L Maxwell Ann C Collier Kevin R Robertson Allison Imrie 《BMC infectious diseases》2007,7(1):37
Background
Cerebrospinal fluid (CSF) pleocytosis may be seen in asymptomatic HIV-infected individuals. This finding complicates interpretation of CSF abnormalities when such individuals are evaluated for other central nervous system infections. The goal of this study was to determine the relationship between CSF pleocytosis, central nervous system (CNS) antiretroviral penetration, adherence to antiretroviral medication regimens, neurological symptoms and performance on neuropsychological tests. 相似文献33.
34.
John P Elliott Niki B Istwan Ann Collins Debbie Rhea Gary Stanziano 《Journal of perinatology》2005,25(1):4-7
OBJECTIVE: To identify the etiology and impact of preterm delivery in twin gestations. STUDY DESIGN: Twin gestations delivered at 33.0 to 36.9 weeks were identified in a perinatal database, and categorized by indication for delivery. Deliveries were identified as indicated, or non-indicated (discretionary). Neonatal outcomes were measured by birth weight, length of stay, NICU admission, and ventilator utilization. Data were divided and analyzed by indicated or discretionary delivery, and gestational age at delivery. RESULTS: Analyzed were 3252 twin gestations (6504 infants), with 78% having indicated delivery. Of the 22% with discretionary delivery, nearly 40% required NICU admission. With each advancing week of gestation, there was a significant decrease in incidence of NICU admission and nursery days. CONCLUSION: The majority of preterm deliveries were indicated, though 22% were discretionary. It is vital to consider neonatal morbidity and costs related to gestational age when choosing discretionary delivery. 相似文献
35.
36.
Weimin Hu Deborah Kelly Barnard Esther Parker Ann Thomas 《环境与职业医学》2007,24(1):117-119
A drinking water supply is a complicated system in its construction,operation,maintenance and need for public health surveillance. 相似文献
37.
38.
39.
Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats. 总被引:2,自引:0,他引:2
T Kuber Sampath Petra Simic Rebecca Sendak Natasa Draca Ann E Bowe Stephen O'Brien Susan C Schiavi John M McPherson Slobodan Vukicevic 《Journal of bone and mineral research》2007,22(6):849-859
We show the systemic administration of low levels of TSH increases bone volume and improves bone microarchitecture and strength in aged OVX rats. TSH's actions are mediated by its inhibitory effects on RANKL-induced osteoclast formation and bone resorption coupled with stimulatory effects on osteoblast differentiation and bone formation, suggesting TSH directly affects bone remodeling in vivo. INTRODUCTION: Thyroid-stimulating hormone (TSH) receptor haploinsufficient mice with normal circulating thyroid hormone levels have reduced bone mass, suggesting that TSH directly affects bone remodeling. We examined whether systemic TSH administration restored bone volume in aged ovariectomized (OVX) rats and influenced osteoclast formation and osteoblast differentiation in vitro. MATERIALS AND METHODS: Sprague-Dawley rats were OVX at 6 months, and TSH therapy was started immediately after surgery (prevention mode; n = 80) or 7 mo later (restoration mode; n = 152). Hind limbs and lumbar spine BMD was measured at 2- or 4-wk intervals in vivo and ex vivo on termination at 8-16 wk. Long bones were subjected to microCT, histomorphometric, and biomechanical analyses. The direct effect of TSH was examined in osteoclast and osteoblast progenitor cultures and established rat osteosarcoma-derived osteoblastic cells. Data were analyzed by ANOVA Dunnett test. RESULTS: In the prevention mode, low doses (0.1 and 0.3 microg) of native rat TSH prevented the progressive bone loss, and importantly, did not increase serum triiodothyroxine (T3) and thyroxine (T4) levels in aged OVX rats. In restoration mode, animals receiving 0.1 and 0.3 microg TSH had increased BMD (10-11%), trabecular bone volume (100-130%), trabecular number (25-40%), trabecular thickness (45-60%), cortical thickness (5-16%), mineral apposition and bone formation rate (200-300%), and enhanced mechanical strength of the femur (51-60%) compared with control OVX rats. In vitro studies suggest that TSH's action is mediated by its inhibitory effects on RANKL-induced osteoclast formation, as shown in hematopoietic stem cells cultivated from TSH-treated OVX rats. TSH also stimulates osteoblast differentiation, as shown by effects on alkaline phosphatase activity, osteocalcin expression, and mineralization rate. CONCLUSIONS: These results show for the first time that systemically administered TSH prevents bone loss and restores bone mass in aged OVX rats through both antiresorptive and anabolic effects on bone remodeling. 相似文献
40.
Shreyasee Amin B Lawrence Riggs Elizabeth J Atkinson Ann L Oberg L Joseph Melton Sundeep Khosla 《Journal of bone and mineral research》2004,19(7):1075-1083
The role of the IGFs and IGFBPs on age-related changes in BMD in adult men and women is not well understood. Studying an age-stratified community based sample of 344 men and 276 women, we found higher IGFBP-2 levels to be associated with lower BMD. IGFBP-2, which increases with age in both men and women, was the strongest, most consistent predictor of BMD among the IGF/IGFBPs studied. INTRODUCTION: Insulin-like growth factors (IGFs) and their binding proteins (IGFBPs) are important regulators of tissue growth and metabolism, but their association with BMD in adult men and women is controversial. MATERIALS AND METHODS: In an age-stratified, random sample of the community population, we examined the role of serum levels of IGF-I, IGF-II, and IGFBP-1, -2, and -3 on BMD of the proximal femur (total hip), lateral spine, midshaft, and ultradistal radius as measured by DXA. We explored the association before and after adjustment for potential confounders, including age, bioavailable estradiol and testosterone, sex hormone binding globulin (SHBG), and measures of total fat and skeletal muscle mass. RESULTS: We studied 344 men (age, 23-90 years) and 276 women (age, 21-93 years; 166 postmenopausal) not on hormone replacement or oral contraceptives. In both men and women, IGF-I and IGFBP-3 levels fell with advancing age, whereas IGFBP-2 levels tended to rise with age. There was an inverse association of IGFBP-2 with BMD at most skeletal sites in men and both premenopausal and postmenopausal women, whereas lower IGF-I and IGFBP-3 were associated with lower BMD in men and postmenopausal women only. Lower IGF-II was associated with lower BMD in men only. There were no associations between IGFBP-1 and BMD in either sex. After adjustment for age, in most cases, we found no further associations between IGF-I, IGF-II, or IGFBP-3 and BMD. In contrast, after age adjustment, higher IGFBP-2 remained a predictor of lower BMD in men and postmenopausal women at all sites except for the lateral spine (for men: r = -0.21, -0.20, and -0.19, all p < 0.001; and for postmenopausal women: r = -0.34, -0.24, and -0.25, all p < 0.01, for the total hip, midshaft, and ultradistal radius, respectively). IGFBP-2 remained an independent negative predictor of BMD in men, postmenopausal women, and all women combined after additional adjustment for bioavailable sex steroids, but not at all sites after adjustment for SHBG and muscle mass. In premenopausal women, IGFBP-2 had similar associations as seen in postmenopausal women, but they were weaker and not statistically robust. CONCLUSIONS: Among the IGF/IGFBPs in our study, IGFBP-2 was a key negative predictor of BMD among men and women, particularly postmenopausal women. Our findings suggest a potential role of the IGF/IGFBP system in regulating bone loss in aging men and women and identify a previously under-recognized, potentially deleterious role for IGFBP-2, a known inhibitor of IGF action that increases with age in both sexes. Whether the action of the IGF/IGFBP system on bone metabolism is mediated partly through its effects on muscle mass or SHBG deserves further study. 相似文献